Congratulations to Novira Therapeutics for its Acquisition Agreement with Johnson & Johnson

We are pleased to share with you that our partner and WuXi Venture Fund portfolio company Novira Therapeutics has agreed to be acquired by Johnson & Johnson.  Novira's lead compound, NVR...

World’s Largest Autism Dataset Goes Online

We are pleased to announce that WuXi NextCODE and Simons Foundation have put the world’s largest autism dataset online, uniting the genome and the internet for real-time queries and collaboration.  Now...

WuXi Teams with Mayo Clinic’s Center for Individualized Medicine to Support Personalized Medicine Discovery

Biomedical research has witnessed dramatic breakthroughs in the genetic roots of disease, the underlying mechanisms of disease progression, and treatment response. Towards building a clearer picture of how systems interact and...

WuXi Acquires Crelux

We are thrilled to announce that we have acquired Crelux GmbH, a leading structure based drug discovery provider based in Munich, Germany. The addition of Crelux enhances WuXi’s structure-based drug discovery capabilities and establishes...

WuXi and MedImmune Form a Strategic Alliance to Develop Innovative Biologics in China for...

We are pleased to announce that we have formed a strategic alliance with MedImmune, the global biologics research and development arm of AstraZeneca to bring cutting-edge research and technical capability for...

SPOTLIGHT

STAY CONNECTED

Twitter LinkedIn 

INNOVATION THAT MATTERS

Inside Perspectives: Gene Editing Takes Center Stage

Depending on the scientific expert, gene editing is just another sophisticated gene therapy tool in the fight against human diseases or a technological advance...